Pharmaron Beijing Co Ltd (SHE:300759) — Stock Price

CN¥47.03 CNY
▲ 3.86% today

Pharmaron Beijing Co Ltd (SHE:300759) is currently trading at CN¥47.03 CNY, up 3.86% today. Over the past 52 weeks, shares have ranged between CN¥21.72 and CN¥47.03. This page tracks Pharmaron Beijing Co Ltd's live share price on the SHE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see 300759 stock market capitalisation.

Pharmaron Beijing Co Ltd (300759) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Pharmaron Beijing Co Ltd's daily closing share price and trading volume on the SHE exchange over the past year, giving a clear view of recent price momentum and liquidity.

Pharmaron Beijing Co Ltd Income Statement — Revenue, Profit & Earnings by Year

Pharmaron Beijing Co Ltd's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20242023202220212020
Total Revenue CN¥12.28 Billion CN¥11.54 Billion CN¥10.27 Billion CN¥7.44 Billion CN¥5.13 Billion
Cost of Revenue CN¥8.09 Billion CN¥7.42 Billion CN¥6.50 Billion CN¥4.77 Billion CN¥3.21 Billion
Gross Profit CN¥4.18 Billion CN¥4.12 Billion CN¥3.76 Billion CN¥2.68 Billion CN¥1.92 Billion
Research & Development CN¥469.26 Million CN¥448.28 Million CN¥282.32 Million CN¥151.77 Million CN¥105.35 Million
SG&A CN¥1.58 Billion CN¥1.61 Billion CN¥1.50 Billion CN¥866.81 Million CN¥653.24 Million
Total Operating Expenses CN¥2.08 Billion CN¥2.27 Billion CN¥2.07 Billion CN¥761.74 Million CN¥595.06 Million
Operating Income CN¥2.10 Billion CN¥1.85 Billion CN¥1.69 Billion CN¥1.91 Billion CN¥1.32 Billion
EBITDA CN¥2.58 Billion CN¥2.43 Billion CN¥2.23 Billion CN¥1.85 Billion CN¥1.32 Billion
EBIT CN¥1.72 Billion CN¥1.69 Billion CN¥1.67 Billion CN¥1.45 Billion CN¥1.02 Billion
Interest Expense CN¥243.72 Million CN¥182.19 Million CN¥167.31 Million CN¥84.46 Million CN¥25.21 Million
Income Before Tax CN¥2.09 Billion CN¥1.84 Billion CN¥1.67 Billion CN¥1.91 Billion CN¥1.32 Billion
Income Tax Expense CN¥377.10 Million CN¥256.11 Million CN¥314.25 Million CN¥290.92 Million CN¥172.38 Million
Net Income CN¥1.79 Billion CN¥1.60 Billion CN¥1.37 Billion CN¥1.66 Billion CN¥1.17 Billion

Pharmaron Beijing Co Ltd Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Pharmaron Beijing Co Ltd's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20242023202220212020
Total Assets CN¥23.93 Billion CN¥26.48 Billion CN¥20.49 Billion CN¥18.39 Billion CN¥11.91 Billion
Total Current Assets CN¥7.61 Billion CN¥10.87 Billion CN¥6.54 Billion CN¥8.64 Billion CN¥5.54 Billion
Cash & Equivalents — — — — —
Short-term Investments CN¥1.12 Billion CN¥594.33 Million CN¥745.36 Million CN¥1.55 Billion CN¥910.01 Million
Net Receivables CN¥3.03 Billion CN¥2.64 Billion CN¥2.21 Billion CN¥1.54 Billion CN¥1.25 Billion
Inventory CN¥1.12 Billion CN¥1.01 Billion CN¥1.04 Billion CN¥680.04 Million CN¥281.62 Million
Property, Plant & Equipment — — — CN¥5.81 Billion CN¥3.80 Billion
Goodwill CN¥2.76 Billion CN¥2.78 Billion CN¥2.69 Billion CN¥2.10 Billion CN¥1.17 Billion
Total Liabilities CN¥9.70 Billion CN¥13.24 Billion CN¥9.65 Billion CN¥8.09 Billion CN¥2.98 Billion
Total Current Liabilities CN¥4.22 Billion CN¥3.65 Billion CN¥3.91 Billion CN¥2.98 Billion CN¥1.98 Billion
Long-term Debt CN¥4.38 Billion CN¥8.20 Billion CN¥4.45 Billion CN¥4.42 Billion CN¥394.81 Million
Net Debt CN¥3.85 Billion CN¥3.44 Billion CN¥4.62 Billion CN¥1.74 Billion CN¥-1.89 Billion
Total Stockholder Equity CN¥13.62 Billion CN¥12.56 Billion CN¥10.55 Billion CN¥10.13 Billion CN¥8.87 Billion
Retained Earnings CN¥6.44 Billion CN¥5.20 Billion CN¥4.15 Billion CN¥3.22 Billion CN¥1.93 Billion

Pharmaron Beijing Co Ltd Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Pharmaron Beijing Co Ltd generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20242023202220212020
Operating Cash Flow CN¥2.58 Billion CN¥2.75 Billion CN¥2.14 Billion CN¥2.06 Billion CN¥1.65 Billion
Capital Expenditures CN¥2.04 Billion CN¥2.87 Billion CN¥2.95 Billion CN¥2.09 Billion CN¥1.32 Billion
Free Cash Flow CN¥536.02 Million CN¥-111.78 Million CN¥-807.04 Million CN¥-34.78 Million CN¥332.77 Million
Investing Cash Flow CN¥-2.02 Billion CN¥-1.35 Billion CN¥-2.21 Billion CN¥-5.26 Billion CN¥-3.37 Billion
Financing Cash Flow CN¥-4.80 Billion CN¥3.92 Billion CN¥-1.42 Billion CN¥3.66 Billion CN¥-280.18 Million
Dividends Paid CN¥542.23 Million CN¥444.79 Million CN¥354.19 Million CN¥237.55 Million CN¥119.14 Million
Stock-Based Compensation — — CN¥177.17 Million CN¥67.53 Million CN¥62.46 Million
Depreciation CN¥1.05 Billion CN¥927.17 Million CN¥696.18 Million CN¥497.92 Million CN¥375.16 Million
Change in Cash CN¥-4.17 Billion CN¥4.43 Billion CN¥-1.41 Billion CN¥415.78 Million CN¥-2.09 Billion

Pharmaron Beijing Co Ltd Earnings History — EPS Actual vs. Analyst Estimates

Track Pharmaron Beijing Co Ltd's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Apr 25, 2026 — — —
Oct 28, 2025 0.25 0.25 +0.00%
Aug 21, 2025 0.20 0.26 -23.08%
Apr 25, 2025 0.16 0.17 -3.29%
Mar 26, 2025 0.21 0.20 +5.00%
Oct 29, 2024 0.18 0.26 -30.77%
Aug 27, 2024 0.16 0.21 -23.81%
Apr 25, 2024 0.10 0.20 -50.00%